(WOOF) Pet Acquisition - Overview
Sector: Consumer Cyclical | Industry: Specialty Retail | Exchange: NASDAQ (USA) | Market Cap: 762m USD | Total Return: -8.8% in 12m
Avg Trading Vol: 6.78M USD
Peers RS (IBD): 30.0
EPS Trend: -64.5%
Qual. Beats: 1
Rev. Trend: -9.7%
Qual. Beats: 0
P/E ratio: 89.3333
Technicals: volatilePetco Health and Wellness Company, Inc. (WOOF) operates in the pet care sector, offering a range of products and services.
Its business model integrates veterinary care, grooming, training, and pet insurance with the sale of pet consumables and supplies. This multi-faceted approach is common in the pet retail industry, which often combines product sales with high-margin services.
Petco utilizes both physical locations and a digital presence through multiple e-commerce platforms. The company also offers proprietary brands such as WholeHearted and Reddy, a strategy used by many retailers to capture greater market share and improve margins.
Further research on ValueRay can provide more in-depth financial and operational insights.
- Pet care services drive recurring revenue growth
- Pet food and supply sales impact overall revenue
- Veterinary services expansion boosts profitability
- Consumer discretionary spending affects pet product demand
- Online sales growth competes with brick-and-mortar stores
| Net Income: 9.07m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 4.57 > 1.0 |
| NWC/Revenue: -1.92% < 20% (prev -2.71%; Δ 0.79% < -1%) |
| CFO/TA 0.08 > 3% & CFO 404.1m > Net Income 9.07m |
| Net Debt (2.60b) to EBITDA (320.5m): 8.12 < 3 |
| Current Ratio: 0.90 > 1.5 & < 3 |
| Outstanding Shares: last quarter (281.2m) vs 12m ago 1.78% < -2% |
| Gross Margin: 38.67% > 18% (prev 0.36%; Δ 3.83k% > 0.5%) |
| Asset Turnover: 115.0% > 50% (prev 117.8%; Δ -2.75% > 0%) |
| Interest Coverage Ratio: 0.95 > 6 (EBITDA TTM 320.5m / Interest Expense TTM 131.2m) |
| A: -0.02 (Total Current Assets 1.02b - Total Current Liabilities 1.13b) / Total Assets 5.17b |
| B: -0.22 (Retained Earnings -1.14b / Total Assets 5.17b) |
| C: 0.02 (EBIT TTM 124.5m / Avg Total Assets 5.18b) |
| D: -0.29 (Book Value of Equity -1.15b / Total Liabilities 4.01b) |
| Altman-Z'' Score: -1.00 = CCC |
| DSRI: 1.16 (Receivables 45.8m/40.4m, Revenue 5.96b/6.12b) |
| GMI: 0.94 (GM 38.67% / 36.36%) |
| AQI: 1.01 (AQ_t 0.43 / AQ_t-1 0.42) |
| SGI: 0.97 (Revenue 5.96b / 6.12b) |
| TATA: -0.08 (NI 9.07m - CFO 404.1m) / TA 5.17b) |
| Beneish M-Score: -3.04 (Cap -4..+1) = AA |
Over the past week, the price has changed by -0.74%, over one month by +1.13%, over three months by -9.76% and over the past year by -8.84%.
- StrongBuy: 0
- Buy: 2
- Hold: 8
- Sell: 2
- StrongSell: 0
| Wallstreet Target Price | 3.5 | 26.6% |
| Analysts Target Price | 3.5 | 26.6% |
P/E Forward = 11.1857
P/S = 0.1278
P/B = 0.6558
Revenue TTM = 5.96b USD
EBIT TTM = 124.5m USD
EBITDA TTM = 320.5m USD
Long Term Debt = 1.49b USD (from longTermDebt, last quarter)
Short Term Debt = 324.7m USD (from shortTermDebt, last quarter)
Debt = 2.86b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.60b USD (from netDebt column, last quarter)
Enterprise Value = 3.37b USD (762.1m + Debt 2.86b - CCE 256.7m)
Interest Coverage Ratio = 0.95 (Ebit TTM 124.5m / Interest Expense TTM 131.2m)
EV/FCF = 11.78x (Enterprise Value 3.37b / FCF TTM 285.8m)
FCF Yield = 8.49% (FCF TTM 285.8m / Enterprise Value 3.37b)
FCF Margin = 4.79% (FCF TTM 285.8m / Revenue TTM 5.96b)
Net Margin = 0.15% (Net Income TTM 9.07m / Revenue TTM 5.96b)
Gross Margin = 38.67% ((Revenue TTM 5.96b - Cost of Revenue TTM 3.66b) / Revenue TTM)
Gross Margin QoQ = 38.33% (prev 38.86%)
Tobins Q-Ratio = 0.65 (Enterprise Value 3.37b / Total Assets 5.17b)
Interest Expense / Debt = 1.10% (Interest Expense 31.6m / Debt 2.86b)
Taxrate = 40.87% (6.27m / 15.3m)
NOPAT = 73.6m (EBIT 124.5m * (1 - 40.87%))
Current Ratio = 0.90 (Total Current Assets 1.02b / Total Current Liabilities 1.13b)
Debt / Equity = 2.46 (Debt 2.86b / totalStockholderEquity, last quarter 1.16b)
Debt / EBITDA = 8.12 (Net Debt 2.60b / EBITDA 320.5m)
Debt / FCF = 9.11 (Net Debt 2.60b / FCF TTM 285.8m)
Total Stockholder Equity = 1.14b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.17% (Net Income 9.07m / Total Assets 5.17b)
RoE = 0.79% (Net Income TTM 9.07m / Total Stockholder Equity 1.14b)
RoCE = 4.73% (EBIT 124.5m / Capital Employed (Equity 1.14b + L.T.Debt 1.49b))
RoIC = 2.72% (NOPAT 73.6m / Invested Capital 2.70b)
WACC = 3.36% (E(762.1m)/V(3.62b) * Re(13.54%) + D(2.86b)/V(3.62b) * Rd(1.10%) * (1-Tc(0.41)))
Discount Rate = 13.54% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 1.22%
[DCF] Terminal Value 80.82% ; FCFF base≈191.3m ; Y1≈125.6m ; Y5≈57.4m
[DCF] Fair Price = N/A (negative equity: EV 1.82b - Net Debt 2.60b = -780.2m; debt exceeds intrinsic value)
EPS Correlation: -64.52 | EPS CAGR: -32.52% | SUE: 1.15 | # QB: 1
Revenue Correlation: -9.73 | Revenue CAGR: 0.70% | SUE: 0.41 | # QB: 0
EPS next Quarter (2026-07-31): EPS=0.08 | Chg7d=-0.012 | Chg30d=-0.012 | Revisions Net=+0 | Analysts=4
EPS current Year (2027-01-31): EPS=0.23 | Chg7d=+0.024 | Chg30d=+0.014 | Revisions Net=+2 | Growth EPS=+23.4% | Growth Revenue=+0.5%
EPS next Year (2028-01-31): EPS=0.26 | Chg7d=+0.049 | Chg30d=+0.042 | Revisions Net=+1 | Growth EPS=+8.9% | Growth Revenue=+1.6%
[Analyst] Revisions Ratio: +0.00 (1 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 12.4% (Discount Rate 13.5% - Earnings Yield 1.1%)
[Growth] Growth Spread = -12.3% (Analyst 0.1% - Implied 12.4%)